Purchases and Sales Made in Q3 2022 in Cerevel Therapeutics Holdings, Inc. (CERE)
This table provides information about the institutional ownership of Cerevel Therapeutics Holdings, Inc. (CERE) during Q3 2022. The information is specifically focused on institutions that hold shares of Cerevel Therapeutics Holdings, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-33.3K- 63.6% |
$850K - $1.38M
|
19.1K
$0
|
|
|
Nov 10, 2022
Q3 2022
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-42.4K- 3.5% |
$1.08M - $1.76M
|
1.17M
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-69.3K- 31.7% |
$1.77M - $2.87M
|
149K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-401K- 85.96% |
$10.2M - $16.6M
|
65.4K
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.53M- 24.25% |
$38.9M - $63.2M
|
4.77M
$0
|